Cape Investment Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cape Investment Advisory’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40	Closed	-$1.16K	–	282
2025 Q4	$1.16K	Sell	40 -50	-56%	-$1.5K	﹤0.01%	1178
2025 Q3	$2.5K	Hold	90	–	–	﹤0.01%	643
2025 Q2	$2.19K	Hold	90	–	–	﹤0.01%	924
2025 Q1	$1.87K	Hold	90	–	–	﹤0.01%	901
2024 Q4	$2.12K	Hold	90	–	–	﹤0.01%	873
2024 Q3	$2.3K	Hold	90	–	–	﹤0.01%	808
2024 Q2	$2.11K	Hold	90	–	–	﹤0.01%	780
2024 Q1	$2.59K	Sell	90 -50	-36%	-$1.5K	﹤0.01%	737
2023 Q4	$4.59K	Hold	140	–	–	﹤0.01%	792
2023 Q3	$3.9K	Hold	140	–	–	﹤0.01%	706
2023 Q2	$4.77K	Hold	140	–	–	﹤0.01%	663
2023 Q1	$4.21K	Buy	+140	New	+$4.34K	﹤0.01%	710

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Cape Investment Advisory's ARKG Position: Q1 2026 in Review

Cape Investment Advisory sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 40 shares — an estimated $1.16K sold.

Cape Investment Advisory first reported a position in ARKG in Q1 2023 and held it in 12 quarters. The position peaked at $4.77K in Q2 2023. 220 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Cape Investment Advisory reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
Cape Investment Advisory sold 40 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $1.16K.
Cape Investment Advisory first reported a position in ARK Genomic Revolution ETF in Q1 2023 and held it in 12 quarters.
Cape Investment Advisory's ARK Genomic Revolution ETF position peaked at $4.77K in Q2 2023.
220 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Cape Investment Advisory's 13F filing for Q1 2026, filed 15 May 2026.